X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
progression-free survival (3507) 3507
science & technology (3267) 3267
life sciences & biomedicine (3225) 3225
humans (3111) 3111
female (2469) 2469
middle aged (2192) 2192
male (2132) 2132
oncology (2084) 2084
aged (2003) 2003
adult (1504) 1504
retrospective studies (988) 988
prognosis (956) 956
aged, 80 and over (916) 916
overall survival (898) 898
treatment outcome (854) 854
cancer (798) 798
chemotherapy (786) 786
disease-free survival (765) 765
patients (645) 645
antineoplastic combined chemotherapy protocols - therapeutic use (628) 628
metastasis (614) 614
survival (610) 610
care and treatment (579) 579
time factors (555) 555
analysis (546) 546
kaplan-meier estimate (546) 546
surgery (475) 475
disease progression (470) 470
risk factors (462) 462
young adult (448) 448
neoplasm staging (440) 440
tumors (423) 423
medical prognosis (396) 396
survival rate (391) 391
research (385) 385
survival analysis (368) 368
development and progression (366) 366
antineoplastic agents - therapeutic use (360) 360
clinical trials (356) 356
medicine & public health (354) 354
follow-up studies (349) 349
adolescent (315) 315
cancer therapies (311) 311
patient outcomes (311) 311
progression free survival (309) 309
proportional hazards models (289) 289
hematology (283) 283
metastases (282) 282
abridged index medicus (275) 275
antineoplastic combined chemotherapy protocols - adverse effects (259) 259
medical research (255) 255
prospective studies (255) 255
drug therapy (246) 246
mutation (240) 240
breast cancer (233) 233
lung neoplasms - drug therapy (230) 230
neurosciences & neurology (223) 223
lung cancer (221) 221
neoplasm metastasis (220) 220
original (218) 218
clinical neurology (210) 210
multivariate analysis (210) 210
randomized controlled trials as topic (209) 209
progression‐free survival (208) 208
health aspects (203) 203
neoplasms. tumors. oncology. including cancer and carcinogens (203) 203
cardiovascular system & cardiology (202) 202
ovarian cancer (200) 200
toxicity (197) 197
medicine, experimental (196) 196
carcinoma, non-small-cell lung - drug therapy (195) 195
studies (194) 194
lung neoplasms - pathology (189) 189
pharmacology & pharmacy (189) 189
general & internal medicine (187) 187
antineoplastic combined chemotherapy protocols - administration & dosage (186) 186
risk assessment (181) 181
medicine, general & internal (180) 180
radiotherapy (178) 178
radiation therapy (177) 177
original article (175) 175
colorectal cancer (174) 174
usage (174) 174
biomarkers (173) 173
research article (171) 171
child (167) 167
lung neoplasms - mortality (166) 166
radiology, nuclear medicine & medical imaging (165) 165
quality of life (159) 159
recurrence (156) 156
immunotherapy (155) 155
predictive value of tests (155) 155
antineoplastic agents - adverse effects (154) 154
carcinoma, non-small-cell lung - pathology (154) 154
urology & nephrology (145) 145
antineoplastic agents - administration & dosage (144) 144
hematology, oncology and palliative medicine (144) 144
genetic aspects (142) 142
biomarkers, tumor - genetics (138) 138
combined modality therapy (138) 138
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4001) 4001
Chinese (46) 46
Korean (22) 22
Russian (18) 18
German (17) 17
Spanish (12) 12
French (11) 11
Japanese (7) 7
Czech (5) 5
Hungarian (5) 5
Polish (4) 4
Turkish (4) 4
Portuguese (3) 3
Arabic (1) 1
Dutch (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 01/2019, Volume 14, Issue 1, pp. 124 - 129
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2018, Volume 36, Issue 4, pp. 383 - 390
Journal Article
Haematologica (Roma), ISSN 1592-8721, 10/2007, Volume 92, Issue 10, pp. 1399 - 1406
...). While in general these data support the association between maximal tumor response and overall survival or progression-free survival after HDT/SCT, some trials have failed to find such correlation... 
Long-term survival | High-dose therapy | Progression-free survival | Multiple myeloma | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | Time Factors | Humans | Survival Rate | Treatment Outcome | Disease Progression | Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2019, Volume 380, Issue 13, pp. 1226 - 1234
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2018, Volume 19, Issue 10, pp. 1315 - 1327
Journal Article